Search

Your search keyword '"Zaniboni A."' showing total 97 results
Start Over Author "Zaniboni A." Journal european journal of cancer
97 results on '"Zaniboni A."'

1. Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer

Author

Pressiani, Tiziana, Balsano, Rita, Giordano, Laura, Milella, Michele, Bergamo, Francesca, Bozzarelli, Silvia, Noventa, Silvia, Ferrrari, Daris, Scartozzi, Mario, Parra, Hector Soto, Auriemma, Alessandra, Soldà, Caterina, Zaniboni, Alberto, Zecchetto, Camilla, Rizzato, Mario Domenico, Rimassa, Lorenza, and Santoro, Armando

Published
2024
Full Text
View/download PDF

2. Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials

Author

Boccaccino, Alessandra, Rossini, Daniele, Raimondi, Alessandra, Carullo, Martina, Lonardi, Sara, Morano, Federica, Santini, Daniele, Tomasello, Gianluca, Niger, Monica, Zaniboni, Alberto, Daniel, Francesca, Bustreo, Sara, Procaccio, Letizia, Clavarezza, Matteo, Cupini, Samanta, Libertini, Michela, Palermo, Federica, Pietrantonio, Filippo, and Cremolini, Chiara

Published
2023
Full Text
View/download PDF

3. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

Author

Bilancia, D., Rosati, G., Montesarchio, V., Iaffaioli, R.V., Nasti, G., Daniele, B., Zagonel, V., Lonardi, S., Pella, N., Aprile, G., Pasini, F., Marchetti, Roma P., Romiti, A., Ciuffreda, L., Ferrari, D., Foa, P., Zaniboni, A., Labianca, R., Mosconi, S., Sobrero, A., Bidoli, P., Cazzaniga, M., Beretta, G.D., Corsi, D.C., Cortesi, E., Barni, S., Petrelli, F., Allione, P., D'Arco, A.M., Valmadre, G., Piazza, E., Veltri, E., Ramus, G. Vietti, Giustini, L., Tumulo, S., Cascinu, S., Granetto, C., Testore, F., Giordano, M., Moroni, M., Di Seri, M., Nuzzo, A., Angelelli, L., Gori, S., Farina, G., Aglietta, M., Franchi, R., Comandé, M., Giordani, P., Tonini, G., Bucci, E., Ballestrero, A., Benasso, M., Graiff, C., Bravi, S., Caffo, O., Silva, R.R., Frontini, L., Rota, S., Cozzi, L., Cantore, M., Maiello, E., Cinieri, S., Silvestris, N., Romito, S., Gebbia, V., Banzi, M., Santoro, A., Artioli, F., Mattioli, R., Contu, A., Di Costanzo, F., Leonardi, F., Cavanna, L., Passalacqua, R., Amoroso, D., Sozzi, P., D'Amico, M., Amadori, D., Frassineti, L., Turci, D., Ravaioli, A., Pasquini, E., Gambi, A., Faedi, M., Cruciani, G., Bajetta, E., Di Bartolomeo, M., Gianni, L., Ronzoni, M., Ionta, M.T., Massidda, B., Scartozzi, M., Zampino, M.G., Bochicchio, A.M., Ciarlo, A., Di Leo, A., Frustaci, S., Rangoni, G., Arizzoia, A., Pavesi, L., Verusio, C., Pinotti, G., Iop, A., De Placido, S., Carlomagno, C., Adamo, V., Ficorella, C., Natale, D., Greco, E., Rulli, E., Galli, F., Poli, D., Porcu, L., Torri, V., Rosati, Gerardo, Lonardi, Sara, Galli, Fabio, Di Bartolomeo, Maria, Ronzoni, Monica, Zampino, Maria G., Banzi, Maria, Zaniboni, Alberto, Pasini, Felice, Bozzarelli, Silvia, Garattini, Silvio K., Ferrari, Daris, Montesarchio, Vincenzo, Mambrini, Andrea, Ciuffreda, Libero, Galli, Francesca, Pusceddu, Valeria, Carlomagno, Chiara, Bidoli, Paolo, Amoroso, Domenico, Bochicchio, Anna M., Frassineti, Luca, Corsi, Domenico, Bilancia, Domenico, Pastorino, Alessandro, De Stefano, Alfonso, and Labianca, Roberto

Published
2021
Full Text
View/download PDF

4. Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies

Author

Rossini, Daniele, Germani, Marco M., Lonardi, Sara, Pietrantonio, Filippo, Dell'Aquila, Emanuela, Borelli, Beatrice, Allegrini, Giacomo, Maddalena, Giulia, Randon, Giovanni, Marmorino, Federica, Zaniboni, Alberto, Buonadonna, Angela, Boccaccino, Alessandra, Conca, Veronica, Antoniotti, Carlotta, Passardi, Alessandro, Masi, Gianluca, and Cremolini, Chiara

Published
2022
Full Text
View/download PDF

5. Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial

Author

Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Daris, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D., Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C., Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, and Perrone, Francesco

Published
2021
Full Text
View/download PDF

6. Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer

Author

Manca, Paolo, Corallo, Salvatore, Randon, Giovanni, Lonardi, Sara, Cremolini, Chiara, Rimassa, Lorenza, Bergamo, Francesca, Antoniotti, Carlotta, Smiroldo, Valeria, Zaniboni, Alberto, Murialdo, Roberto, Tampellini, Marco, Tomasello, Gianluca, Clavarezza, Matteo, Racca, Patrizia, Antista, Maria, Raimondi, Alessandra, Prisciandaro, Michele, Pagani, Filippo, Palermo, Federica, Greco, Francesca Gabriella, Vaiani, Marta, Di Bartolomeo, Maria, de Braud, Filippo, Calareso, Giuseppina, Morano, Federica, and Pietrantonio, Filippo

Published
2021
Full Text
View/download PDF

8. Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy—a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest

Author

Moretto, Roberto, Rossini, Daniele, Zucchelli, Gemma, Lonardi, Sara, Bergamo, Francesca, Santini, Daniele, Cupini, Samanta, Tomasello, Gianluca, Caponnetto, Salvatore, Zaniboni, Alberto, Antoniotti, Carlotta, Pietrantonio, Filippo, Buonadonna, Angela, Marmorino, Federica, Bordonaro, Roberto, Fea, Elena, Tamburini, Emiliano, Boccaccino, Alessandra, Grande, Roberta, Aprile, Giuseppe, Falcone, Alfredo, and Cremolini, Chiara

Published
2020
Full Text
View/download PDF

9. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study

Author

Raimondi, Alessandra, Di Maio, Massimo, Morano, Federica, Corallo, Salvatore, Lonardi, Sara, Antoniotti, Carlotta, Rimassa, Lorenza, Sartore-Bianchi, Andrea, Tampellini, Marco, Ritorto, Giuliana, Murialdo, Roberto, Clavarezza, Matteo, Zaniboni, Alberto, Adamo, Vincenzo, Tomasello, Gianluca, Petrelli, Fausto, Antonuzzo, Lorenzo, Giordano, Monica, Cinieri, Saverio, Longarini, Raffaella, Bergamo, Francesca, Niger, Monica, Antista, Maria, Peverelli, Giorgia, de Braud, Filippo, Di Bartolomeo, Maria, and Pietrantonio, Filippo

Published
2020
Full Text
View/download PDF

11. Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients

Author

Cascinu, Stefano, Rosati, Gerardo, Bilancia, Domenico, Nasti, Guglielmo, Iaffaioli, Rosario Vincenzo, Lonardi, Sara, Zagonel, Vittorina, Zaniboni, Alberto, Marchetti, Paolo, Romiti, Adriana, Leone, Francesco, Aglietta, Massimo, Giordano, Monica, Corsi, Domenico C., Ferraú, Francesco, Labianca, Roberto, Mosconi, Stefania, Ronzoni, Monica, Gianni, Luca, Rulli, Eliana, Poli, Davide, Galli, Francesca, Torri, Valter, De Simone, Irene, Galli, Fabio, Pasini, Felice, Rangoni, Giovanni, Venezia, Raffaele, Sozzi, Pietro, Nuzzo, Antonio, Berardi, Rossana, Frontini, Luciano, Rota, Silvia, Cozzi, Lorena, and Scartozzi, Mario

Published
2017
Full Text
View/download PDF

12. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Author

Thaler, Josef, Greil, Richard, Gaenzer, Johannes, Eisterer, Wolfgang, Tschmelitsch, Joerg, Keil, Felix, Samonigg, Hellmut, Zabernigg, August, Schmid, Franz, Steger, Günther, Steinacher, Robert, Andel, Johannes, Jagdt, Björn, Lang, Alois, Fridrik, Michael, Függer, Reinhold, Hofbauer, Friedrich, Woell, Ewald, Geissler, Dietmar, Lenauer, Alfred, Prager, Manfred, D'Haens, Geert, Demolin, Gauthier, Kerger, Joseph, Deboever, Guido, Ghillebert, Gilbert, Polus, Marc, Van Cutsem, Eric, Kalantari, Hassan Rezaie, Delaunoit, Thierry, Goeminne, Jean Charles, Peeters, Marc, Vergauwe, Philippe, Houbiers, Ghislain, Humblet, Yves, Janssens, Jos, Schrijvers, Dirk, Vanderstraeten, Erik, Van Laethem, Jean-Luc, Vermorken, Jan, Van Daele, Daniel, Ferrante, Michel, Forget, Frederic, Hendlisz, Alain, Yilmaz, Mette, Nielsen, Svend Erik, Vestermark, Lene, Larsen, Jim, Zawadi, Mohamed-Ayman, Bouche, Olivier, Mineur, Laurent, Bennouna-Louridi, Jaafar, Dourthe, Louis Marie, Ychou, Marc, Boucher, Eveline, Taieb, Julien, Pezet, Denis, Desseigne, Francoise, Ducreux, Michel, Texereau, Patrick, Miglianico, Laurent, Rougier, Philippe, Fratte, Serge, Levache, Charles-Briac, Merrouche, Yacine, Ellis, Stephen, Locher, Christophe, Ramee, Jean-Francois, Garnier, Claire, Viret, Frederic, Chauffert, Bruno, Cojean-Zelek, Isabelle, Michel, Pierre, Lecaille, Cedric, Borel, Christian, Seitz, Jean-Francois, Smith, Denis, Lombard-Bohas, Catherine, Andre, Thierry, Gornet, Jean-Marc, Fein, Francine, Coulon-Sfairi, Marie-Aude, Kaminsky, Marie-Christine, Lagasse, Jean-Paul, Luet, Dominique, Etienne, Pierre-Luc, Gasmi, Mohamed, Vanoli, Andre, Nguyen, Suzanne, Aparicio, Thomas, Perrier, Hervé, Stremsdoerfer, Noel, Laplaige, Philippe, Arsene, Dominique, Auby, Dominique, Bedenne, Laurent, Coriat, Romain, Denis, Bernard, Geoffroy, Patrick, Piot, Gilles, Becouarn, Yves, Bordes, Gilbert, Deplanque, Gael, Dupuis, Olivier, Fruge, Frederic, Guimbaud, Rosine, Lecomte, Thierry, Lledo, Gérard, Sobhani, Iradej, Asnacios, Amani, Azzedine, Ahmed, Desauw, Christophe, Galais, Marie-Pierre, Gargot, Dany, Lam, You-Heng, Abakar-Mahamat, Abakar, Berdah, Jean-Francois, Catteau, Sylviane, Clavero-Fabri, Marie-Christine, Codoul, Jean-Francois, Legoux, Jean-Louis, Goldfain, Denis, Guichard, Pierre, Verge, Denis Pere, Provencal, Jocelyne, Vedrenne, Bruno, Brezault-Bonnet, Catherine, Cleau, Denis, Desir, Jean-Paul, Fallik, David, Garcia, Bruno, Gaspard, Marie-Hélène, Genet, Dominique, Hartwig, Johannes, Krummel, Yves, Budnik, Tamara Matysiak, Palascak-Juif, Vanessa, Randrianarivelo, Harizo, Rinaldi, Yves, Aleba, Albert, Darut-Jouve, Ariane, de Gramont, Aimery, Hamon, Herve, Wendehenne, Frederic, Matzdorff, Axel, Stahl, Michael Konrad, Schepp, Wolfgang, Burk, Martin, Mueller, Lothar, Folprecht, Gunnar, Geissler, Michael, Mantovani-Loeffler, Luisa, Hoehler, Thomas, Asperger, Walter, Kroening, Hendrik, von Weikersthal, Ludwig Fischer, Fuxius, Stefan, Groschek, Matthias, Meiler, Johannes, Trarbach, Tanja, Rauh, Jacqueline, Ziegenhagen, Nicolas, Kretzschmar, Albrecht, Graeven, Ullrich, Nusch, Arnd, von Wichert, Goetz, Hofheinz, Ralf-Dieter, Kleber, Gerhard, Schmidt, Karl-Heinz, Vehling-Kaiser, Ursula, Baum, Claudia, Schuette, Jochen, Haag, Georg Martin, Holtkamp, Wilhelm, Potenberg, Jochen, Reiber, Tobias, Schliesser, Georg, Schmoll, Hans-Joachim, Schneider-Kappus, Wolfgang, Abenhardt, Wolfgang, Denzlinger, Claudio, Henning, Jan, Marxsen, Bartscht, Derigs, Hans Guenter, Lambertz, Helmut, Becker-Boost, Ingulf, Caca, Karel, Constantin, Christian, Decker, Thomas, Eschenburg, Henning, Gabius, Sigrun, Hebart, Holger, Hoffmeister, Albrecht, Horst, Heinz-August, Kremers, Stephan, Leithaeuser, Malte, Mueller, Sebastian, Wagner, Siegfried, Daum, Severin, Schlegel, Frank, Stauch, Martina, Heinemann, Volker, Maiello, Evaristo, Latini, Luciano, Zaniboni, Alberto, Amadori, Dino, Aprile, Giuseppe, Barni, Sandro, Mattioli, Rodolfo, Martoni, Andrea, Passalacqua, Rodolfo, Nicolini, Mario, Pasquini, Enzo, Rabbi, Carla, Aitini, Enrico, Ravaioli, Alberto, Barone, Carlo, Biasco, Guido, Tamberi, Stefano, Gambi, Angelo, Verusio, Claudio, Marzola, Marina, Lelli, Giorgio, Boni, Corrado, Cascinu, Stefano, Bidoli, Paolo, Vaghi, Massimo, Cruciani, Giorgio, Di Costanzo, Francesco, Sobrero, Alberto, Mini, Enrico, Petrioli, Roberto, Aglietta, Massimo, Alabiso, Oscar, Capuzzo, Federico, Falcone, Alfredo, Corsi, Domenico Cristi, Labianca, Roberto, Salvagni, Stefania, Chiara, Silvana, Ciuffreda, Libero, Ferraù, Francesco, Giuliani, Francesco, Lonardi, Sara, Gebbia, Nicola, Mantovani, Giovanni, Sanches, Evaristo, Mellidez, Juan Carlos, Santos, Pedro, Freire, Joao, Sarmento, Cristina, Costa, Luis, Pinto, Antonio Moreira, Barroso, Sergio, Santo, Jorge Espirito, Guedes, Fátima, Monteiro, Amélia, Sa, Anabela, Furtado, Irene, Salazar, Ramon, Aguilar, Enrique Aranda, Herrero, Fernando Rivera, Tabernero, Josep, Valera, Javier Sastre, Ayerbes, Manuel Valladares, Batlle, Jaime Feliu, Gil, Silvia, Esteve, Albert Abad, Garcia-Giron, Carlos, Vivanco, Guillermo Lopez, Salvia, Antonia Salud, Orduña, Vicente Alonso, Garcia, Ruth Vera, Gallego, Javier, Sureda, Bartomeu Massuti, Remon, Jordi, Safont Aguilera, Maria Jose, Nogueras, Luis Cirera, Merino, Bernado Queralt, Castro, Cristina Gravalos, de Prado, Purificacion Martinez, Pericay, Carlos Pijaume, Figueiras, Manuel Constenla, Jordan, Inmaculada Guasch, Gome Reina, Maria Jose, Garcia, Amelia Lopez-Ladron, Garcia-Ramos, Antonio Arrivi, Cervantes, Andres, Martos, Carlos Fernandez, Gaspar, Eugenio Marcuello, Montero, Ines Cabezas, Emperador, Pilar Escudero, Carbonero, Ana Leon, Castillo, Manuel Gallen, Garcia, Teresa Garcia, Lopez, Jose Garcia, Flores, Encarnacion Gonzalez, Morales, Monica Guillot, Muñoz, Marta Llanos, Martín, Ana López, Maurel, Joan, Camara, Juan Carlos, Garcia, Rosario Dueñas, Salgado, Mercedes, Busquier, Isabel Hernandez, Ruiz, Teresa Checa, Muñoa, Adelaida Lacasta, Aliguer, Miquel Nogue, de Taranco, Amalia Velasco Ortiz, Ureña, Miguel Mendez, Gaspa, Ferran Losa, Ponce, Jose Juan, Roig, Carlos Bosch, Jimenez, Pedro Valero, Brotons, Antonio Galan, Rodriguez, Santiago Albiol, Martinez, Jose Ales, Ruiz, Liliana Canosa, Ruiz, Margarita Centelles, Bridgewater, John, Glynne-Jones, Rob, Tahir, Saad, Hickish, Tamas, Cassidy, Jim, Samuel, Leslie, Emile, Jean-François, Julié, Catherine, Le Malicot, Karine, Lepage, Come, Dimet, Stéphanie, Boulagnon-Rombi, Camille, Allard, Marc-Antoine, Penault-Llorca, Frédérique, Bennouna, Jaafar, and Laurent-Puig, Pierre

Published
2017
Full Text
View/download PDF

13. FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies

Author

Antoniotti, Carlotta, primary, Germani, Marco M., additional, Rossini, Daniele, additional, Lonardi, Sara, additional, Pietrantonio, Filippo, additional, Santini, Daniele, additional, Marmorino, Federica, additional, Allegrini, Giacomo, additional, Daniel, Francesca, additional, Raimondi, Alessandra, additional, Borelli, Beatrice, additional, Zaniboni, Alberto, additional, Conca, Veronica, additional, Abraham, Jim, additional, Spetzler, David, additional, Maiello, Evaristo, additional, Boccaccino, Alessandra, additional, Passardi, Alessandro, additional, Giordano, Mirella, additional, Tamburini, Emiliano, additional, Korn, Michael W., additional, Masi, Gianluca, additional, and Cremolini, Chiara, additional

Published
2022
Full Text
View/download PDF

14. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

Author

Rosati, Gerardo, primary, Lonardi, Sara, additional, Galli, Fabio, additional, Di Bartolomeo, Maria, additional, Ronzoni, Monica, additional, Zampino, Maria G., additional, Banzi, Maria, additional, Zaniboni, Alberto, additional, Pasini, Felice, additional, Bozzarelli, Silvia, additional, Garattini, Silvio K., additional, Ferrari, Daris, additional, Montesarchio, Vincenzo, additional, Mambrini, Andrea, additional, Ciuffreda, Libero, additional, Galli, Francesca, additional, Pusceddu, Valeria, additional, Carlomagno, Chiara, additional, Bidoli, Paolo, additional, Amoroso, Domenico, additional, Bochicchio, Anna M., additional, Frassineti, Luca, additional, Corsi, Domenico, additional, Bilancia, Domenico, additional, Pastorino, Alessandro, additional, De Stefano, Alfonso, additional, Labianca, Roberto, additional, Bilancia, D., additional, Rosati, G., additional, Montesarchio, V., additional, Iaffaioli, R.V., additional, Nasti, G., additional, Daniele, B., additional, Zagonel, V., additional, Lonardi, S., additional, Pella, N., additional, Aprile, G., additional, Pasini, F., additional, Marchetti, Roma P., additional, Romiti, A., additional, Ciuffreda, L., additional, Ferrari, D., additional, Foa, P., additional, Zaniboni, A., additional, Labianca, R., additional, Mosconi, S., additional, Sobrero, A., additional, Bidoli, P., additional, Cazzaniga, M., additional, Beretta, G.D., additional, Corsi, D.C., additional, Cortesi, E., additional, Barni, S., additional, Petrelli, F., additional, Allione, P., additional, D'Arco, A.M., additional, Valmadre, G., additional, Piazza, E., additional, Veltri, E., additional, Ramus, G. Vietti, additional, Giustini, L., additional, Tumulo, S., additional, Cascinu, S., additional, Granetto, C., additional, Testore, F., additional, Giordano, M., additional, Moroni, M., additional, Di Seri, M., additional, Nuzzo, A., additional, Angelelli, L., additional, Gori, S., additional, Farina, G., additional, Aglietta, M., additional, Franchi, R., additional, Comandé, M., additional, Giordani, P., additional, Tonini, G., additional, Bucci, E., additional, Ballestrero, A., additional, Benasso, M., additional, Graiff, C., additional, Bravi, S., additional, Caffo, O., additional, Silva, R.R., additional, Frontini, L., additional, Rota, S., additional, Cozzi, L., additional, Cantore, M., additional, Maiello, E., additional, Cinieri, S., additional, Silvestris, N., additional, Romito, S., additional, Gebbia, V., additional, Banzi, M., additional, Santoro, A., additional, Artioli, F., additional, Mattioli, R., additional, Contu, A., additional, Di Costanzo, F., additional, Leonardi, F., additional, Cavanna, L., additional, Passalacqua, R., additional, Amoroso, D., additional, Sozzi, P., additional, D'Amico, M., additional, Amadori, D., additional, Frassineti, L., additional, Turci, D., additional, Ravaioli, A., additional, Pasquini, E., additional, Gambi, A., additional, Faedi, M., additional, Cruciani, G., additional, Bajetta, E., additional, Di Bartolomeo, M., additional, Gianni, L., additional, Ronzoni, M., additional, Ionta, M.T., additional, Massidda, B., additional, Scartozzi, M., additional, Zampino, M.G., additional, Bochicchio, A.M., additional, Ciarlo, A., additional, Di Leo, A., additional, Frustaci, S., additional, Rangoni, G., additional, Arizzoia, A., additional, Pavesi, L., additional, Verusio, C., additional, Pinotti, G., additional, Iop, A., additional, De Placido, S., additional, Carlomagno, C., additional, Adamo, V., additional, Ficorella, C., additional, Natale, D., additional, Greco, E., additional, Rulli, E., additional, Galli, F., additional, Poli, D., additional, Porcu, L., additional, and Torri, V., additional

Published
2021
Full Text
View/download PDF

16. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Author

Emile, Jean-François, primary, Julié, Catherine, additional, Le Malicot, Karine, additional, Lepage, Come, additional, Tabernero, Josep, additional, Mini, Enrico, additional, Folprecht, Gunnar, additional, Van Laethem, Jean-Luc, additional, Dimet, Stéphanie, additional, Boulagnon-Rombi, Camille, additional, Allard, Marc-Antoine, additional, Penault-Llorca, Frédérique, additional, Bennouna, Jaafar, additional, Laurent-Puig, Pierre, additional, Taieb, Julien, additional, Thaler, Josef, additional, Greil, Richard, additional, Gaenzer, Johannes, additional, Eisterer, Wolfgang, additional, Tschmelitsch, Joerg, additional, Keil, Felix, additional, Samonigg, Hellmut, additional, Zabernigg, August, additional, Schmid, Franz, additional, Steger, Günther, additional, Steinacher, Robert, additional, Andel, Johannes, additional, Jagdt, Björn, additional, Lang, Alois, additional, Fridrik, Michael, additional, Függer, Reinhold, additional, Hofbauer, Friedrich, additional, Woell, Ewald, additional, Geissler, Dietmar, additional, Lenauer, Alfred, additional, Prager, Manfred, additional, D'Haens, Geert, additional, Demolin, Gauthier, additional, Kerger, Joseph, additional, Deboever, Guido, additional, Ghillebert, Gilbert, additional, Polus, Marc, additional, Van Cutsem, Eric, additional, Kalantari, Hassan Rezaie, additional, Delaunoit, Thierry, additional, Goeminne, Jean Charles, additional, Peeters, Marc, additional, Vergauwe, Philippe, additional, Houbiers, Ghislain, additional, Humblet, Yves, additional, Janssens, Jos, additional, Schrijvers, Dirk, additional, Vanderstraeten, Erik, additional, Vermorken, Jan, additional, Van Daele, Daniel, additional, Ferrante, Michel, additional, Forget, Frederic, additional, Hendlisz, Alain, additional, Yilmaz, Mette, additional, Nielsen, Svend Erik, additional, Vestermark, Lene, additional, Larsen, Jim, additional, Zawadi, Mohamed-Ayman, additional, Bouche, Olivier, additional, Mineur, Laurent, additional, Bennouna-Louridi, Jaafar, additional, Dourthe, Louis Marie, additional, Ychou, Marc, additional, Boucher, Eveline, additional, Pezet, Denis, additional, Desseigne, Francoise, additional, Ducreux, Michel, additional, Texereau, Patrick, additional, Miglianico, Laurent, additional, Rougier, Philippe, additional, Fratte, Serge, additional, Levache, Charles-Briac, additional, Merrouche, Yacine, additional, Ellis, Stephen, additional, Locher, Christophe, additional, Ramee, Jean-Francois, additional, Garnier, Claire, additional, Viret, Frederic, additional, Chauffert, Bruno, additional, Cojean-Zelek, Isabelle, additional, Michel, Pierre, additional, Lecaille, Cedric, additional, Borel, Christian, additional, Seitz, Jean-Francois, additional, Smith, Denis, additional, Lombard-Bohas, Catherine, additional, Andre, Thierry, additional, Gornet, Jean-Marc, additional, Fein, Francine, additional, Coulon-Sfairi, Marie-Aude, additional, Kaminsky, Marie-Christine, additional, Lagasse, Jean-Paul, additional, Luet, Dominique, additional, Etienne, Pierre-Luc, additional, Gasmi, Mohamed, additional, Vanoli, Andre, additional, Nguyen, Suzanne, additional, Aparicio, Thomas, additional, Perrier, Hervé, additional, Stremsdoerfer, Noel, additional, Laplaige, Philippe, additional, Arsene, Dominique, additional, Auby, Dominique, additional, Bedenne, Laurent, additional, Coriat, Romain, additional, Denis, Bernard, additional, Geoffroy, Patrick, additional, Piot, Gilles, additional, Becouarn, Yves, additional, Bordes, Gilbert, additional, Deplanque, Gael, additional, Dupuis, Olivier, additional, Fruge, Frederic, additional, Guimbaud, Rosine, additional, Lecomte, Thierry, additional, Lledo, Gérard, additional, Sobhani, Iradej, additional, Asnacios, Amani, additional, Azzedine, Ahmed, additional, Desauw, Christophe, additional, Galais, Marie-Pierre, additional, Gargot, Dany, additional, Lam, You-Heng, additional, Abakar-Mahamat, Abakar, additional, Berdah, Jean-Francois, additional, Catteau, Sylviane, additional, Clavero-Fabri, Marie-Christine, additional, Codoul, Jean-Francois, additional, Legoux, Jean-Louis, additional, Goldfain, Denis, additional, Guichard, Pierre, additional, Verge, Denis Pere, additional, Provencal, Jocelyne, additional, Vedrenne, Bruno, additional, Brezault-Bonnet, Catherine, additional, Cleau, Denis, additional, Desir, Jean-Paul, additional, Fallik, David, additional, Garcia, Bruno, additional, Gaspard, Marie-Hélène, additional, Genet, Dominique, additional, Hartwig, Johannes, additional, Krummel, Yves, additional, Budnik, Tamara Matysiak, additional, Palascak-Juif, Vanessa, additional, Randrianarivelo, Harizo, additional, Rinaldi, Yves, additional, Aleba, Albert, additional, Darut-Jouve, Ariane, additional, de Gramont, Aimery, additional, Hamon, Herve, additional, Wendehenne, Frederic, additional, Matzdorff, Axel, additional, Stahl, Michael Konrad, additional, Schepp, Wolfgang, additional, Burk, Martin, additional, Mueller, Lothar, additional, Geissler, Michael, additional, Mantovani-Loeffler, Luisa, additional, Hoehler, Thomas, additional, Asperger, Walter, additional, Kroening, Hendrik, additional, von Weikersthal, Ludwig Fischer, additional, Fuxius, Stefan, additional, Groschek, Matthias, additional, Meiler, Johannes, additional, Trarbach, Tanja, additional, Rauh, Jacqueline, additional, Ziegenhagen, Nicolas, additional, Kretzschmar, Albrecht, additional, Graeven, Ullrich, additional, Nusch, Arnd, additional, von Wichert, Goetz, additional, Hofheinz, Ralf-Dieter, additional, Kleber, Gerhard, additional, Schmidt, Karl-Heinz, additional, Vehling-Kaiser, Ursula, additional, Baum, Claudia, additional, Schuette, Jochen, additional, Haag, Georg Martin, additional, Holtkamp, Wilhelm, additional, Potenberg, Jochen, additional, Reiber, Tobias, additional, Schliesser, Georg, additional, Schmoll, Hans-Joachim, additional, Schneider-Kappus, Wolfgang, additional, Abenhardt, Wolfgang, additional, Denzlinger, Claudio, additional, Henning, Jan, additional, Marxsen, Bartscht, additional, Derigs, Hans Guenter, additional, Lambertz, Helmut, additional, Becker-Boost, Ingulf, additional, Caca, Karel, additional, Constantin, Christian, additional, Decker, Thomas, additional, Eschenburg, Henning, additional, Gabius, Sigrun, additional, Hebart, Holger, additional, Hoffmeister, Albrecht, additional, Horst, Heinz-August, additional, Kremers, Stephan, additional, Leithaeuser, Malte, additional, Mueller, Sebastian, additional, Wagner, Siegfried, additional, Daum, Severin, additional, Schlegel, Frank, additional, Stauch, Martina, additional, Heinemann, Volker, additional, Maiello, Evaristo, additional, Latini, Luciano, additional, Zaniboni, Alberto, additional, Amadori, Dino, additional, Aprile, Giuseppe, additional, Barni, Sandro, additional, Mattioli, Rodolfo, additional, Martoni, Andrea, additional, Passalacqua, Rodolfo, additional, Nicolini, Mario, additional, Pasquini, Enzo, additional, Rabbi, Carla, additional, Aitini, Enrico, additional, Ravaioli, Alberto, additional, Barone, Carlo, additional, Biasco, Guido, additional, Tamberi, Stefano, additional, Gambi, Angelo, additional, Verusio, Claudio, additional, Marzola, Marina, additional, Lelli, Giorgio, additional, Boni, Corrado, additional, Cascinu, Stefano, additional, Bidoli, Paolo, additional, Vaghi, Massimo, additional, Cruciani, Giorgio, additional, Di Costanzo, Francesco, additional, Sobrero, Alberto, additional, Petrioli, Roberto, additional, Aglietta, Massimo, additional, Alabiso, Oscar, additional, Capuzzo, Federico, additional, Falcone, Alfredo, additional, Corsi, Domenico Cristi, additional, Labianca, Roberto, additional, Salvagni, Stefania, additional, Chiara, Silvana, additional, Ciuffreda, Libero, additional, Ferraù, Francesco, additional, Giuliani, Francesco, additional, Lonardi, Sara, additional, Gebbia, Nicola, additional, Mantovani, Giovanni, additional, Sanches, Evaristo, additional, Mellidez, Juan Carlos, additional, Santos, Pedro, additional, Freire, Joao, additional, Sarmento, Cristina, additional, Costa, Luis, additional, Pinto, Antonio Moreira, additional, Barroso, Sergio, additional, Santo, Jorge Espirito, additional, Guedes, Fátima, additional, Monteiro, Amélia, additional, Sa, Anabela, additional, Furtado, Irene, additional, Salazar, Ramon, additional, Aguilar, Enrique Aranda, additional, Herrero, Fernando Rivera, additional, Valera, Javier Sastre, additional, Ayerbes, Manuel Valladares, additional, Batlle, Jaime Feliu, additional, Gil, Silvia, additional, Esteve, Albert Abad, additional, Garcia-Giron, Carlos, additional, Vivanco, Guillermo Lopez, additional, Salvia, Antonia Salud, additional, Orduña, Vicente Alonso, additional, Garcia, Ruth Vera, additional, Gallego, Javier, additional, Sureda, Bartomeu Massuti, additional, Remon, Jordi, additional, Safont Aguilera, Maria Jose, additional, Nogueras, Luis Cirera, additional, Merino, Bernado Queralt, additional, Castro, Cristina Gravalos, additional, de Prado, Purificacion Martinez, additional, Pericay, Carlos Pijaume, additional, Figueiras, Manuel Constenla, additional, Jordan, Inmaculada Guasch, additional, Gome Reina, Maria Jose, additional, Garcia, Amelia Lopez-Ladron, additional, Garcia-Ramos, Antonio Arrivi, additional, Cervantes, Andres, additional, Martos, Carlos Fernandez, additional, Gaspar, Eugenio Marcuello, additional, Montero, Ines Cabezas, additional, Emperador, Pilar Escudero, additional, Carbonero, Ana Leon, additional, Castillo, Manuel Gallen, additional, Garcia, Teresa Garcia, additional, Lopez, Jose Garcia, additional, Flores, Encarnacion Gonzalez, additional, Morales, Monica Guillot, additional, Muñoz, Marta Llanos, additional, Martín, Ana López, additional, Maurel, Joan, additional, Camara, Juan Carlos, additional, Garcia, Rosario Dueñas, additional, Salgado, Mercedes, additional, Busquier, Isabel Hernandez, additional, Ruiz, Teresa Checa, additional, Muñoa, Adelaida Lacasta, additional, Aliguer, Miquel Nogue, additional, de Taranco, Amalia Velasco Ortiz, additional, Ureña, Miguel Mendez, additional, Gaspa, Ferran Losa, additional, Ponce, Jose Juan, additional, Roig, Carlos Bosch, additional, Jimenez, Pedro Valero, additional, Brotons, Antonio Galan, additional, Rodriguez, Santiago Albiol, additional, Martinez, Jose Ales, additional, Ruiz, Liliana Canosa, additional, Ruiz, Margarita Centelles, additional, Bridgewater, John, additional, Glynne-Jones, Rob, additional, Tahir, Saad, additional, Hickish, Tamas, additional, Cassidy, Jim, additional, and Samuel, Leslie, additional

Published
2017
Full Text
View/download PDF

17. Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A “real life” study

Author

Giordano, G., primary, Lo Re, G., additional, Milella, M., additional, Di Marco, M., additional, Melisi, D., additional, Passardi, A., additional, Iop, A., additional, Febbraro, A., additional, Foltran, L., additional, Francesca, B., additional, Bertocchi, P., additional, Vaccaro, V., additional, Aloi, M.B., additional, Giommoni, E., additional, Ricci, V., additional, Vasile, E., additional, Zaniboni, A., additional, Zagone, V., additional, and De Vita, F., additional

Published
2017
Full Text
View/download PDF

18. 2143 Regorafenib for previously treated metastatic colorectal cancer (mCRC): Results from 683 Italian patients treated in the open-label phase 3B CONSIGN study

Author

Corrado Boni, A. Russo, Gabriele Luppi, M. Moscovici, Giacomo Cartenì, M. Di Bartolomeo, Alberto Sobrero, Evaristo Maiello, Antonella Santoro, F. Di Constanzo, S. Siena, A. Falcone, A. Zaniboni, Fortunato Ciardiello, Stefano Cascinu, C. Barone, E. Van Cutsem, and Vittorina Zagonel

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Colorectal cancer, medicine.disease, chemistry.chemical_compound, chemistry, Regorafenib, Internal medicine, medicine, Open label, Previously treated, business
Published
2015
Full Text
View/download PDF

19. 2139 CONSIGN: An open-label phase 3B study of regorafenib in patients with metastatic colorectal cancer (mCRC) who failed standard therapy

Author

Rocio Garcia-Carbonero, A. Grothey, Joachim Kalmus, Jeremy Shapiro, Fortunato Ciardiello, J.F. Seitz, Alfredo Falcone, E. Van Cutsem, Ashok Miriyala, Alberto Zaniboni, R.D. Hofheinz, and Udit Verma

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Colorectal cancer, medicine.disease, chemistry.chemical_compound, chemistry, Internal medicine, Regorafenib, medicine, In patient, Open label, business, Standard therapy
Published
2015
Full Text
View/download PDF

20. Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The 'GISCAD' experience

Author

G. Pancera, G. Giaccon, G. Fiorentini, G. Dallavalle, Stefano Cascinu, A. Zaniboni, R. Labianca, M. Duro, G. Ambrosini, G. Luporini, Guido Martignoni, A. Iirillo, Sandro Barni, Cristina Oliani, and E. Piazza

Subjects
Cancer Research, medicine.medical_specialty, business.industry, Colorectal cancer, Alpha interferon, medicine.disease, Gastroenterology, Surgery, Folinic acid, Oncology, Fluorouracil, Internal medicine, Toxicity, medicine, Mucositis, business, Progressive disease, Interferon alfa, medicine.drug
Abstract

In advanced colorectal cancer the addition of folinic acid (FA) has been shown to lead to increased activity, at least in terms of response rate, in comparison with 5-fluorouracil (5FU) alone. Similarly, interferon-α (IFN) is able to potentiate 5FU, although high doses cause heavy toxicity. Given the different mechanisms of action of the two agents, the double modulation of 5FU deserves clinical evaluation. In a multicenter study (involving both primary care and referral institutions) 63 patients with advanced colorectal cancer, previously untreated with chemotherapy, received, in an outpatient setting, FA (200 mg/m 2 i.v. bolus) + 5FU (400 mg/m 2 i.v. in 15 min) for 5 consecutive days every 4 weeks + IFN 3 × 10 6 U on alternate days, starting 1 week before chemotherapy. During the 5 days of 5FU + FA, IFN was administered daily. The antitumour activity, the impact on response duration and survival and toxicity of the combination were evaluated according to WHO criteria. Of the 63 enrolled patients, 56 were evaluable: there were 2 complete responses (3%) and 13 partial responses (21%), giving an objective response rate of 24% (95% confidence interval 13–35%); no change was observed in 17 cases and progressive disease in 24. Median duration of response was 9 months and median survival (all patients) 13 months. Toxicity was acceptable, even though 4 patients presented reversible grade 4 side-effects (2 mucositis and 2 diarrhoea). With this schedule and these doses, addition of IFN did not lead to any increase in the activity of 5FU + FA. In colorectal cancer, further clinical studies with these drugs should be based on a deeper experimental knowledge of their mechanisms of interaction.

Published
1994
Full Text
View/download PDF

21. Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group

Author

P. Nelli, Daniele Fagnani, M. Di Bartolomeo, A. Iirillo, Anna Maria Bochicchio, M. Visini, Gabriella Farina, Emilio Bajetta, Giuseppe Schieppati, A. Zaniboni, Federico Bozzetti, G P Ianniello, P. Comella, R. Franchi, C. Casartelli, Vittorio Gebbia, C. Ferroni, Graziella Pinotti, G. Ucci, F. de Braud, and Roberto Buzzoni

Subjects
Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Phases of clinical research, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Mucositis, Humans, Etoposide, Aged, Chemotherapy, Performance status, business.industry, Middle Aged, Prognosis, medicine.disease, Hematologic Diseases, Regimen, Tolerability, Doxorubicin, Female, Cisplatin, business, medicine.drug
Abstract

Various reports have documented the efficacy of the combination of etoposide, doxorubicin and cisplatin (EAP) in the treatment of advanced gastric cancer, although other studies have not confirmed such results. This multicentre phase II study was designed to try to define the efficacy and tolerability of the original EAP regimen. From January 1990 to May 1992, 96 patients with locally advanced or metastatic gastric cancer were treated every 3 weeks with etoposide (120 mg/m2) on days 4, 5 and 6, doxorubicin (20 mg/m2) on days 1 and 7, and cisplatin (40 mg/m2) on days 2 and 8. All of the patients had measurable lesions, and were to receive a maximum of six cycles. A total of 416 courses was given (median four/patient), 27% with a delay of > or = 2 weeks. Objective responses were achieved in 34 of the 91 evaluable patients (37%: confidence interval 27-47%), with complete response (CR) in 11 (12%) and partial response (PR) in 23 (25%). The median duration of response was 6 months (range 1-19), and the median survival of the 96 eligible patients was 9 months. Side-effects (WHO grade 3-4) were leucopenia (30%), thrombocytopenia (9%) and mucositis (10%). We conclude that the EAP regimen is active in inducing major objective responses (12% of CR), and that treatment is feasible in patients with good performance status.

Published
1994
Full Text
View/download PDF

22. Steroid receptor enhancement by natural interferon-β in advanced breast cancer

Author

Francesco Lo Sardo, Mario Baroni, Paolo Malacarne, Gina Lama, Gioacchino Robustelli della Cuna, Fortunata Iacopino, Alberto Pellegrini, Paolo Marchetti, Alberto Zaniboni, Dino Amadori, and Gigliola Sica

Subjects
Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Advanced breast, Mammary gland, Breast Neoplasms, Steroid, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, skin and connective tissue diseases, Receptor, Aged, business.industry, Cancer, Interferon-beta, Immunotherapy, Middle Aged, medicine.disease, Tamoxifen, Steroid hormone, Endocrinology, medicine.anatomical_structure, Receptors, Estrogen, Oncology, Cancer research, Female, Receptors, Progesterone, business, medicine.drug
Abstract

In the current study we investigated the effect of two different doses of natural interferon-beta (IFN-beta) on steroid hormone receptors in 45 patients with advanced breast cancer. IFN-beta seems to regulate the receptor mechanisms, inducing in cutaneous metastases an increase of oestrogen and progesterone receptors. Moreover, using IFN-beta and tamoxifen as a combined therapy in 23 receptor-positive patients, no negative interference of the two drugs was observed and no relevant side-effects due to the treatment were noticed. The modulation of steroid receptor content by IFN-beta in advanced breast cancer might represent an interesting way to ameliorate the clinical responsiveness to anti-oestrogens.

Published
1993
Full Text
View/download PDF

23. 2139 CONSIGN: An open-label phase 3B study of regorafenib in patients with metastatic colorectal cancer (mCRC) who failed standard therapy

Author

Van Cutsem, E., primary, Ciardiello, F., additional, Seitz, J.F., additional, Hofheinz, R.D., additional, Verma, U., additional, Garcia-Carbonero, R., additional, Grothey, A., additional, Miriyala, A., additional, Kalmus, J., additional, Shapiro, J., additional, Falcone, A., additional, and Zaniboni, A., additional

Published
2015
Full Text
View/download PDF

24. 2150 Low rates of hospitalizations with TAS-102 in the European (EU) subregion of the Phase 3 RECOURSE trial in patients (pts) with metastatic colorectal cancer (mCRC)

Author

Falcone, A., primary, Garcia-Carbonero, R., additional, Tabernero, J., additional, Sobrero, A., additional, Peeters, M., additional, Zaniboni, A., additional, Hochster, H., additional, Lenz, H.J., additional, Tran, B., additional, Yamaguchi, K., additional, Muro, K., additional, Denda, T., additional, Tsuji, Y., additional, Wahba, M., additional, Benedetti, F., additional, Ohtsu, A., additional, Mayer, R.J., additional, and Van Cutsem, E., additional

Published
2015
Full Text
View/download PDF

25. 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian “real life” study

Author

Giordano, G., primary, Febbraro, A., additional, Vaccaro, V., additional, Zagonel, V., additional, De Giorgi, U., additional, Melisi, D., additional, Vasile, E., additional, Bianco, R., additional, Lo Re, G., additional, Valente, M., additional, Formica, V., additional, Montesarchio, V., additional, Maiorino, L., additional, Sanna, G., additional, Bittoni, A., additional, Ricci, V., additional, Santini, D., additional, Zaniboni, A., additional, Milella, M., additional, and De Vita, F., additional

Published
2015
Full Text
View/download PDF

26. 2143 Regorafenib for previously treated metastatic colorectal cancer (mCRC): Results from 683 Italian patients treated in the open-label phase 3B CONSIGN study

Author

Ciardiello, F., primary, Falcone, A., additional, Cascinu, S., additional, Sobrero, A., additional, Boni, C., additional, Barone, C., additional, Luppi, G., additional, Maiello, E., additional, Siena, S., additional, Zagonel, V., additional, Carteni, G., additional, Constanzo, F. Di, additional, Bartolomeo, M. Di, additional, Santoro, A., additional, Russo, A., additional, Moscovici, M., additional, Van Cutsem, E., additional, and Zaniboni, A., additional

Published
2015
Full Text
View/download PDF

27. 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts)

Author

Giordano, G., primary, De Vita, F., additional, Melisi, D., additional, Vaccaro, V., additional, Zaniboni, A., additional, Zagonel, V., additional, Vasile, E., additional, Passardi, A., additional, Leo, L., additional, Ventriglia, J., additional, Marciano, R., additional, Russano, M., additional, Conca, R., additional, Andreozzi, F., additional, Lucchini, E., additional, Musettini, G., additional, Bertocchi, P., additional, Bergamo, F., additional, Milella, M., additional, and Febbraro, A., additional

Published
2015
Full Text
View/download PDF

28. 2006 A phase III multicenter trial comparing two different sequences of second/third line therapy (cetuximab/irinotecan followed by FOLFOX versus FOLFOX followed by cetuximab/irinotecan) in metastatic K-RAS wt colorectal cancer (mCC) patients, refractory to FOLFIRI/Bevacizumab)

Author

Cascinu, S., primary, Lonardi, S., additional, Rosati, G., additional, Nasti, G., additional, Zaniboni, A., additional, Romiti, A., additional, Aglietta, M., additional, Bilancia, D., additional, Iaffaioli, V., additional, Zagonel, V., additional, Giordano, M., additional, Corsi, D., additional, Ferraù, F., additional, Labianca, R., additional, Berardi, R., additional, Rulli, E., additional, and Floriani, I., additional

Published
2015
Full Text
View/download PDF

29. 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian 'real life' study

Author

Roberto Bianco, V. Zagonel, Vincenzo Ricci, G. Sanna, Luigi Maiorino, Daniele Santini, Davide Melisi, A. Zaniboni, Alessandro Bittoni, U. De Giorgi, G. Lo Re, Vincenzo Montesarchio, M. Milella, M.M. Valente, Vanja Vaccaro, Vincenzo Formica, F. De Vita, Enrico Vasile, Antonio Febbraro, and G. Giordano

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.disease, Gemcitabine, Internal medicine, Pancreatic cancer, medicine, First line chemotherapy, Life study, business, medicine.drug, Nab-paclitaxel
Published
2015
Full Text
View/download PDF

30. 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts)

Author

Jole Ventriglia, R. Conca, Vanja Vaccaro, L. Leo, V. Zagonel, A. Zaniboni, Francesca Bergamo, Enrico Vasile, Davide Melisi, F Andreozzi, Antonio Febbraro, G. Giordano, Eleonora Lucchini, Alessandro Passardi, F. De Vita, Gianna Musettini, M. Milella, Roberta Marciano, Marco Russano, and Paola Bertocchi

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, First line, medicine.disease, Gemcitabine, Pancreatic cancer, Internal medicine, medicine, business, Nab-paclitaxel, medicine.drug
Published
2015
Full Text
View/download PDF

31. 2150 Low rates of hospitalizations with TAS-102 in the European (EU) subregion of the Phase 3 RECOURSE trial in patients (pts) with metastatic colorectal cancer (mCRC)

Author

Tadamichi Denda, J. Tabernero, Robert J. Mayer, Rocio Garcia-Carbonero, Alberto Sobrero, Kei Muro, M. Wahba, Monika Peeters, A. Ohtsu, Ben Tran, Kensei Yamaguchi, Fabio Benedetti, Yasushi Tsuji, Alberto Zaniboni, Howard S. Hochster, E. Van Cutsem, H. J. Lenz, and Alfredo Falcone

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, business.industry, Internal medicine, medicine, In patient, medicine.disease, business, Surgery
Published
2015
Full Text
View/download PDF

32. 2006 A phase III multicenter trial comparing two different sequences of second/third line therapy (cetuximab/irinotecan followed by FOLFOX versus FOLFOX followed by cetuximab/irinotecan) in metastatic K-RAS wt colorectal cancer (mCC) patients, refractory to FOLFIRI/Bevacizumab)

Author

Massimo Aglietta, Monica Giordano, Francesco Ferraù, Vincenzo Rosario Iaffaioli, Domenico Corsi, Sara Lonardi, Guglielmo Nasti, A. Zaniboni, R. Labianca, Eliana Rulli, Vittorina Zagonel, Rossana Berardi, A. Romiti, Irene Floriani, Stefano Cascinu, Domenico Bilancia, and Gerardo Rosati

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Colorectal cancer, Third-line therapy, medicine.disease, FOLFOX, Refractory, Internal medicine, Multicenter trial, FOLFIRI, medicine, Cetuximab/Irinotecan, business, medicine.drug
Published
2015
Full Text
View/download PDF

33. 638 - Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A “real life” study

Author

Giordano, G., Lo Re, G., Milella, M., Di Marco, M., Melisi, D., Passardi, A., Iop, A., Febbraro, A., Foltran, L., Francesca, B., Bertocchi, P., Vaccaro, V., Aloi, M.B., Giommoni, E., Ricci, V., Vasile, E., Zaniboni, A., Zagone, V., and De Vita, F.

Published
2017
Full Text
View/download PDF

35. 1005 ORAL HER-3, IGF-1, NF K-B and EGFR Gene Copy Number in the Prediction of Clinical Outcome for Colorectal Cancer Patients Receiving Irinotecan-cetuximab

Author

Alessandra Mandolesi, L. Fotios, Riccardo Giampieri, Elena Maccaroni, Stefano Cascinu, Rossana Berardi, A. Zaniboni, Alfredo Falcone, Mario Scartozzi, and Italo Bearzi

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Cetuximab, business.industry, Colorectal cancer, medicine.disease, Irinotecan, Internal medicine, medicine, Copy-number variation, business, medicine.drug
Published
2011
Full Text
View/download PDF

36. 735 L-Leucovorin (LLV) as a modulator of 5-days 5-fluorouracil (5FU) in advanced colorectal cancer (ACC): High dose (HD) versus low dose (LD)

Author

A.C. Luporini, Stefano Cascinu, G. Fiorentini, R. Labianca, L. Frontini, Giuseppe Comella, G. Luporini, A. Zaniboni, G. Dallavalle, G. Pancera, Sandro Barni, and A. Pessi

Subjects
Cancer Research, medicine.medical_specialty, business.industry, Low dose, medicine.disease, Gastroenterology, Surgery, Advanced colorectal cancer, Regimen, Oncology, Fluorouracil, Internal medicine, Toxicity, medicine, Mucositis, L-Leucovorin, business, Objective response, medicine.drug
Abstract

LV has a defined activity in the biochemical modulation of 5FU so that in ACC LV + 5FU is superior to 5FU alone in term of objective response (O.R.); the 5 days regimen with LD-LV appears active as HD-LV weekly administered. In this multicentric phase III study from 11/91 to 6/94, 422 patients (pts) were randomized between L LV 100 mg/sqm/iv x 5 d (arm A) versus L LV 10 mg/sqm/iv × 5 d (arm B). All pts received 5FU: 370 mg/sqm/iv × 5 d. Treatment was recycled every 28 d. Toxicity was acceptable in both groups with only 11% of pts experiencing grade 3–4 diarrhea and mucositis. At a median follow-up of 18 m, of 372 pts evaluable we observed similar activity: 20 OR (10.6%) in arm A (3 of them complete) and 21 (11.4%)OR in arm B, with 4 CR. No differences were observed in overall survival: 10 m for both groups. In this study HD- L LV and LD- L LV appear equally active in biochemical modulation of 5-d 5FU with lower costs for LD- L LV

Published
1995
Full Text
View/download PDF

38. 735 L-Leucovorin (LLV) as a modulator of 5-days 5-fluorouracil (5FU) in advanced colorectal cancer (ACC): High dose (HD) versus low dose (LD)

Author

Labianca, R., primary, Cascinu, S., additional, Barni, S., additional, Fiorentini, G., additional, Frontini, L., additional, Comella, G., additional, Zaniboni, A., additional, Dallavalle, G., additional, Pancera, G., additional, Luporini, A.C., additional, Pessi, A., additional, and Luporini, G., additional

Published
1995
Full Text
View/download PDF

40. Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience

Author

Labianca, R., primary, Giaccon, G., additional, Barni, S., additional, Ambrosini, G., additional, Iirillo, A., additional, Fiorentini, G., additional, Duro, M., additional, Piazza, E., additional, Oliani, C., additional, Pancera, G., additional, Cascinu, S., additional, Martignoni, G., additional, Zaniboni, A., additional, Dallavalle, G., additional, and Luporini, G., additional

Published
1994
Full Text
View/download PDF

47. Low-dose 6-S leucovorin (LLV) AND 5-fluorouracil (5-FU) as salvage treatment in metastatic breast cancer (MBC)

Author

Giuseppina Arcangeli, A. Alghisi, E. Arnoldi, Alberto Zaniboni, Giovanni Marini, and Fausto Meriggi

Subjects
Levoleucovorin, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Salvage treatment, Low dose, medicine.disease, Metastatic breast cancer, Fluorouracil, Internal medicine, medicine, business, medicine.drug
Published
1994
Full Text
View/download PDF

50. Leuprolide and tamoxifen in the treatment of pancreatic cancer. A phase II study

Author

A. Alghisi, Alberto Zaniboni, C Huscher, Giovanni Marini, Fausto Meriggi, and Giuseppina Arcangeli

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, MEDLINE, Phases of clinical research, medicine.disease, Clinical trial, Text mining, Internal medicine, Pancreatic cancer, medicine, business, Tamoxifen, medicine.drug
Published
1994
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results